New chemo cocktail shows promise for invasive bladder cancer
NCT ID NCT01616875
First seen Mar 25, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tested a combination of two chemotherapy drugs, cabazitaxel and cisplatin, given before surgery to remove the bladder in people with invasive bladder cancer. The goal was to see if the drugs could shrink the tumor enough to improve outcomes. 28 patients took part, and the results will help decide if this approach should be studied further in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bristol Haematology + Oncology Centre, Horfield Road
Bristol, BS2 8ED, United Kingdom
Conditions
Explore the condition pages connected to this study.